檢索結果 - Susan O'Brien

Refine Results
  1. 1
    Initial treatment of CLL: integrating biology and functional status

    Initial treatment of CLL: integrating biology and functional status 由 Nitin Jain, Susan O’Brien

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia

    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia... 由 Paolo Strati, Susan O’Brien

    出版 2013
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  3. 3
    Immune defects in patients with chronic lymphocytic leukemia

    Immune defects in patients with chronic lymphocytic leukemia 由 Farhad Ravandi, Susan O’Brien

    出版 2005
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Update on Therapy of Chronic Lymphocytic Leukemia

    Update on Therapy of Chronic Lymphocytic Leukemia 由 John G. Gribben, Susan O’Brien

    出版 2011
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Chronic Lymphocytic Leukemia: Diagnosis and Treatment

    Chronic Lymphocytic Leukemia: Diagnosis and Treatment 由 Paolo Strati, Nitin Jain, Susan O’Brien

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments] 由 HM Kantarjian, Susan O’Brien, Paolo Anderlini, Moshe Talpaz

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Discontinuation of imatinib therapy after achieving a molecular response

    Discontinuation of imatinib therapy after achieving a molecular response 由 Jorge E. Cortés, Susan O’Brien, Hagop M. Kantarjian

    出版 2004
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  8. 8
    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval 由 Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortés

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia 由 Susan O’Brien, Auro del Giglio, Michael J. Keating

    出版 1995
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Acute lymphoblastic leukemia in adolescents and young adults

    Acute lymphoblastic leukemia in adolescents and young adults 由 Michael Rytting, Elias Jabbour, Susan O’Brien, Hagop M. Kantarjian

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Monoclonal antibodies in acute lymphoblastic leukemia

    Monoclonal antibodies in acute lymphoblastic leukemia 由 Elias Jabbour, Susan O’Brien, Farhad Ravandi, Hagop M. Kantarjian

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia

    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia 由 Elias Jabbour, Susan O’Brien, Marina Konopleva, Hagop M. Kantarjian

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia 由 Hagop M. Kantarjian, Deborah A. Thomas, Alan S. Wayne, Susan O’Brien

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma

    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma 由 Preetesh Jain, Luis Fayad, Andreas Rosenwald, Ken H. Young, Susan O’Brien

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis 由 Amit Bar‐Or, Susan O’Brien, Michael Sweeney, Edward Fox, Jeffrey A. Cohen

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia

    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia 由 Michael Rytting, Lisa Triche, Deborah A. Thomas, Susan O’Brien, Hagop M. Kantarjian

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Imatinib mesylate causes hypopigmentation in the skin

    Imatinib mesylate causes hypopigmentation in the skin 由 Anne S. Tsao, Hagop M. Kantarjian, Jorge E. Cortés, Susan O’Brien, Moshe Talpaz

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia

    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine... 由 Kensuke Kojima, Marina Konopleva, Teresa McQueen, Susan O’Brien, William Plunkett, Michael Andreeff

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options

    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options 由 Theresa Liu-Dumlao, Hagop M. Kantarjian, Deborah A. Thomas, Susan O’Brien, Farhad Ravandi

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  20. 20
    Current and emerging treatment options in chronic myeloid leukemia

    Current and emerging treatment options in chronic myeloid leukemia 由 Elias Jabbour, Jorge E. Cortés, Francis J. Giles, Susan O’Brien, Hagop M. Kantarjian

    出版 2007
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: